Loading clinical trials...
Loading clinical trials...
A Double-Blind, Placebo-Controlled, Multicenter Study of Sirukumab as Adjunctive Treatment to a Monoaminergic Antidepressant in Adults With Major Depressive Disorder
Conditions
Interventions
Sirukumab 50 mg
Placebo
Locations
46
United States
Birmingham, Alabama, United States
Little Rock, Arkansas, United States
Bellflower, California, United States
Glendale, California, United States
Lemon Grove, California, United States
Orange, California, United States
Start Date
July 23, 2015
Primary Completion Date
May 22, 2018
Completion Date
May 22, 2018
Last Updated
April 29, 2025
NCT05415397
NCT07059234
NCT06396312
NCT06136546
NCT06398496
NCT06417619
Lead Sponsor
Janssen Research & Development, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions